Skip to main content

Search complete. 26 mentions across 2 episodes found for "PNKP".

Sep 10, 2026

Islam MohamedGUEST
7:32
It's headquartered in Calgary, and we're developing a first-in-class DNA damage response inhibitor against a novel target.
Islam MohamedGUEST
7:39
So that's a DNA repair enzyme called polynucleotide kinase phosphatase, or PNKP.
Islam MohamedGUEST
7:46
As far as we're aware, there is no clinical stage PNKP program anywhere in the world.
Islam MohamedGUEST
7:51
We hold exclusive worldwide rights to the University of Alberta's foundational PNKP inhibitor patents, together with an exclusive sub-license to the nanoparticle delivery platform that accompanies it.
Islam MohamedGUEST
8:05
Our lead candidate in this space is Onco10.
Islam MohamedGUEST
8:10
That's a combination of the PNKP inhibitor called A83B4C63.
Islam MohamedGUEST
8:16
And that's encapsulated within a nanoparticle to improve how long it circulates and how it accumulates in the tumor.
Islam MohamedGUEST
8:23
So in laboratory and animal studies, it demonstrates two distinct behaviors.
Islam MohamedGUEST
7:32
It's headquartered in Calgary, and we're developing a first-in-class DNA damage response inhibitor against a novel target.
Islam MohamedGUEST
7:39
So that's a DNA repair enzyme called polynucleotide kinase phosphatase, or PNKP.
Islam MohamedGUEST
7:46
As far as we're aware, there is no clinical stage PNKP program anywhere in the world.
Islam MohamedGUEST
7:51
And we hold exclusive worldwide rights to the University of Alberta's foundational PNKP inhibitor patents, together with an exclusive sub-license to the nanoparticle delivery platform that accompanies it.
Islam MohamedGUEST
8:05
So our lead candidate in this space is Onco10.
Islam MohamedGUEST
8:10
So that's a combination of the PNKP inhibitor called A83B4C63, and that's encapsulated within a nanoparticle to improve how long it circulates and how it accumulates in the tumor.
Islam MohamedGUEST
8:23
In laboratory and animal studies, it demonstrates two distinct behaviors.
Islam MohamedGUEST
8:27
In tumors that have lost a tumor suppressor gene, one called PTEN or P10, and another one called SHP1, It can kill cancer cells acting via synthetic lethality just with the drug alone.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.